Reply from the authors
Reply from the authors
- Research Article
8
- 10.1053/j.ackd.2014.01.005
- Mar 1, 2014
- Advances in Chronic Kidney Disease
B Cell Suppression in Primary Glomerular Disease
- Research Article
136
- 10.1053/j.ackd.2020.09.003
- Sep 1, 2020
- Advances in Chronic Kidney Disease
Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19.
- Front Matter
114
- 10.1053/j.ajkd.2021.06.004
- Jun 25, 2021
- American Journal of Kidney Diseases
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
- Research Article
101
- 10.1038/ki.2013.476
- Jun 1, 2014
- Kidney International
Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
- Research Article
38
- 10.1074/jbc.m110.133959
- Aug 1, 2010
- Journal of Biological Chemistry
Focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome and end-stage renal disease worldwide. Although the mechanisms underlying this important disease are poorly understood, the glomerular podocyte clearly plays a central role in disease pathogenesis. In the current work, we demonstrate that the homophilic adhesion molecule sidekick-1 (sdk-1) is up-regulated in podocytes in FSGS both in rodent models and in human kidney biopsy samples. Transgenic mice that have podocyte-specific overexpression of sdk-1 develop gradually progressive heavy proteinuria and severe FSGS. We also show that sdk-1 associates with the slit diaphragm linker protein MAGI-1, which is already known to interact with several critical podocyte proteins including synaptopodin, alpha-actinin-4, nephrin, JAM4, and beta-catenin. This interaction is mediated through a direct interaction between the carboxyl terminus of sdk-1 and specific PDZ domains of MAGI-1. In vitro expression of sdk-1 enables a dramatic recruitment of MAGI-1 to the cell membrane. Furthermore, a truncated version of sdk-1 that is unable to bind to MAGI-1 does not induce podocyte dysfunction when overexpressed. We conclude that the up-regulation of sdk-1 in podocytes is an important pathogenic factor in FSGS and that the mechanism involves disruption of the actin cytoskeleton possibly via alterations in MAGI-1 function.
- Front Matter
- 10.1053/j.ajkd.2012.10.003
- Dec 13, 2012
- American Journal of Kidney Diseases
Screening Strategies for Tuberculosis in Children With Kidney Disease: What Is Cost-Effective?
- Front Matter
13
- 10.1053/j.ajkd.2008.05.002
- Jun 24, 2008
- American Journal of Kidney Diseases
Obesity and CKD: How to Assess the Risk?
- Research Article
127
- 10.1046/j.1523-1755.2002.00674.x
- Dec 1, 2002
- Kidney International
Treatment of primary focal segmental glomerulosclerosis
- Research Article
- 10.1053/ajkd.2000.8297
- Jul 1, 2000
- American Journal of Kidney Diseases
Authors' reply:
- Research Article
19
- 10.1053/j.ackd.2019.01.003
- Mar 1, 2019
- Advances in chronic kidney disease
The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
- Research Article
10
- 10.1111/ajt.14088
- Nov 18, 2016
- American Journal of Transplantation
Light Chain Podocytopathy Mimicking Recurrent Focal Segmental Glomerulosclerosis.
- Front Matter
9
- 10.1053/j.ajkd.2009.09.017
- Nov 17, 2009
- American Journal of Kidney Diseases
First Identification of an Antigen in Autoimmune Idiopathic Membranous Nephropathy: Toward Targeted Therapy?
- Research Article
74
- 10.1016/j.kint.2017.03.005
- May 3, 2017
- Kidney International
Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases
- Front Matter
8
- 10.1053/j.ajkd.2013.03.016
- May 2, 2013
- American Journal of Kidney Diseases
Circulating Antipodocyte Antibodies in Membranous Nephropathy: Pathophysiologic and Clinical Relevance
- Research Article
3
- 10.1016/j.ekir.2021.06.010
- Jun 22, 2021
- Kidney International Reports
Repository Corticotropin Injections Promote Clinical Remission and Regulatory T Cell Expansion in Membranous Nephropathy